Capsule Commentary on Jin et. al., Cost-Effectiveness of Primary HPV Testing, Cytology and Co-testing as Cervical Cancer Screening for Women above Age 30 Years

被引：0

作者：

Walsh, Judith ^{[1
]}

机构：

[1] Univ Calif San Francisco, Div Gen Internal Med, Womens Hlth Ctr Excellence, San Francisco, CA 94143 USA

来源：

关键词：

Cervical Cancer Screening; Capsule Commentary; Major Society Guidelines; Colposcopy; Cervical Cytology;

D O I：

10.1007/s11606-016-3796-x

中图分类号：

R19 [保健组织与事业（卫生事业管理）];

学科分类号：

摘要：

[No abstract available]

引用

页码：1358 / 1358

页数：1

共 4 条

[1] [Anonymous], 2016, Obstet Gynecol, V157, pe1, DOI [10.1097/aog.0000000000001263, DOI 10.1097/AOG.0000000000001256, DOI 10.1097/AOG.0000000000001263, 10.1097/AOG.0000000000001256]
[2] Use of primary high-risk human papillomavirus testing for cervical cancer screening: Interim clinical guidance
Huh, Warner K.
Ault, Kevin A.
Chelmow, David
Davey, Diane D.
Goulart, Robert A.
Garcia, Francisco A. R.
Kinney, Walter K.
Massad, L. Stewart
Mayeaux, Edward J.
Saslow, Debbie
Schiffman, Mark
Wentzensen, Nicolas
Lawson, Herschel W.
Einstein, Mark H.
[J]. GYNECOLOGIC ONCOLOGY, 2015, 136 (02) : 178 - 182
[3] Jin XW, 2016, J GEN INTERN MED, DOI [10.1007/s11606-016-3772-50, DOI 10.1007/S11606-016-3772-50.]
[4] Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement
Moyer, Virginia A.
[J]. ANNALS OF INTERNAL MEDICINE, 2012, 156 (12) : 880 - U91